Medical cost-offset following treatment referral for alcohol and other drug use disorders in a group model HMO

Journal of Behavioral Health Services and Research

Volumn 33, Issue 3, 2006, Pages 335-346

  Polen, Michael R ^a   Freeborn, Donald K ^a   Lynch, Frances L ^a   Mullooly, John P ^a   Dickinson, Daniel M ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADDICTION SEVERITY INDEX; ADULT; ALCOHOL ABUSE; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG DEPENDENCE TREATMENT; FEMALE; HEALTH CARE COST; HEALTH MAINTENANCE ORGANIZATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PREDICTION; RATING SCALE; SUBSTANCE ABUSE; TREATMENT OUTCOME; ADDICTION; COMPARATIVE STUDY; COST CONTROL; MIDDLE AGED; PATIENT REFERRAL; UNITED STATES;

ADULT; COST CONTROL; FEMALE; HEALTH EXPENDITURES; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; OREGON; REFERRAL AND CONSULTATION; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 33748109699     PISSN: 10943412     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11414-006-9020-8     Document Type: Article

References (24)

1. Holder HD, Blose JO. Alcoholism treatment and total health care utilization and costs. A four-year longitudinal analysis of federal employees. Journal of the American Medical Association. 1986;256:1456-1460.
2. Holder HD, Blose JO. The reduction of health care costs associated with alcoholism treatment: a 14-year longitudinal study. Journal of Studies on Alcohol. 1992;53:293-302.
3. Reiff S, Griffiths B, Forsythe AB, et al. Utilization of medical services by alcoholics participating in a health maintenance organization outpatient treatment program: three-year follow-up. Alcohol: Clinical and Experimental Research. 1981;5:559-562.
4. Cartwright WS. Cost-benefit analysis of drug treatment services: review of the literature. Journal of Mental Health Policy and Economics. 2000;3:11-26.
5. Harwood HJ, Malhotra D, Villarivera C, et al. Cost effectiveness and cost benefit analysis of substance abuse treatment: A literature review. NEDS Contract No. 270-00-7078. 2002. Falls Church, VA, The Lewin Group.
6. Holder HD. Alcoholism treatment and potential health care cost saving. Medical Care. 1987;25:52-71.
7. Holder HD, Lennox RD, Blose JO. The economic benefits of alcoholism treatment: a summary of twenty years of research. Journal of Employee Assistance Research. 1992;1:63-81.
8. Jones KR, Vischi TR. Impact of alcohol, drug abuse and mental health treatment on medical care utilization. A review of the research literature. Medical Care. 1979;17(Suppl 2):1-82.
9. Institute of Medicine. Broadening the Base of Treatment for Alcohol Problems. Washington DC: National Academy Press, 1990.
10. Goodman AC, Tilford JM, Hankin JR, et al. Alcoholism treatment offset effects: an insurance perspective. Medical Care Research Review. 2000;57:51-75.
11. Parthasarathy S, Weisner C, Hu TW, et al. Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis. Journal of Studies on Alcohol. 2001;62:89-97.
12. Kane RL, Wall M, Potthoff S, et al. The effect of alcoholism treatment on medical care use. Medical Care. 2004;42:395-402.
13. Hoffmann NG, DeHart SS, Fulkerson JA. Medical care utilization as a function of recovery status following chemical addictions treatment. Journal of Addictive Diseases. 1993;12:97-108.
14. Freeborn DK, Pope CR. Promise and Performance in Managed Care: The Prepaid Group Practice Model. Baltimore, MD: The Johns Hopkins University Press, 1994.
15. Green CA, Polen MR, Dickinson DM, et al. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. Journal of Substance Abuse Treatment. 2002;23:285-295.
16. Green CA, Polen MR, Lynch FL, et al. Gender differences in outcomes in an HMO-based substance abuse treatment program. Journal of Addictive Diseases. 2004;23:47-70.
17. McLellan AT, Kushner H, Metzger D, et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 1992;9:199-213.
18. Hornbrook MC, Goodman MJ. Chronic disease, functional health status, and demographics: a multi-dimensional approach to risk adjustment. Health Services Research 1996;31:283-307.
19. SAS Institute Inc. SAS/STAT User's Guide, Version 8, Volumes 1, 2, and 3. Cary, NC: SAS Institute Inc., 2000.
20. Diehr P, Yanez D, Ash A, et al. Methods for analyzing health care utilization and costs. Annual Review of Public Health. 1999;20:125-144.
21. Arbuckle JL, Wothke W. Amos 4.0 User's Guide. Chicago, IL: Small Waters Corporation, 1999.
22. McLellan AT, Lewis DC, O'Brien CP, et al. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association 2000;284:1689-1695.
23. Sturm R. Economic grand rounds: the myth of medical cost-offset. Psychiatric Services 2001;52:738-740.
24. McLellan AT, McKay JR, Forman R, et al. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction 2005;100:447-458.